Symbol="SELB"
AssetType="Common Stock"
Name="Selecta Biosciences Inc"
Description="Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human disease. The company is headquartered in Watertown, Massachusetts."
CIK="1453687"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="480 ARSENAL WAY, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="168770000"
EBITDA="-13474000"
PERatio="None"
PEGRatio="0"
BookValue="0.486"
DividendPerShare="0"
DividendYield="0"
EPS="-0.13"
RevenuePerShareTTM="0.544"
ProfitMargin="-0.182"
OperatingMarginTTM="-0.177"
ReturnOnAssetsTTM="-0.0606"
ReturnOnEquityTTM="-0.231"
RevenueTTM="82716000"
GrossProfitTTM="38400000"
DilutedEPSTTM="-0.13"
QuarterlyEarningsGrowthYOY="0.537"
QuarterlyRevenueGrowthYOY="-0.825"
AnalystTargetPrice="4.67"
TrailingPE="-"
ForwardPE="25.45"
PriceToSalesRatioTTM="1.544"
PriceToBookRatio="2.361"
EVToRevenue="0.744"
EVToEBITDA="2.007"
Beta="1.144"
num_52WeekHigh="2.6"
num_52WeekLow="0.9"
num_50DayMovingAverage="1.154"
num_200DayMovingAverage="1.333"
SharesOutstanding="153427000"
DividendDate="None"
ExDividendDate="None"
symbol="SELB"
open="1.12"
high="1.14"
low="1.09"
price="1.10"
volume="517054.00"
latest_trading_day="2023-08-11"
previous_close="1.12"
change="-0.02"
change_percent="-1.7857%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="66"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="34"
Volume_recent_avg="1209436"
Change_recent_avg="0.01"
Delta_recent_avg="0.08"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.21"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="34"
Aroon_momentum_negative="66"
image_negative_thumbnail_id_1="1102"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0135.jpeg"
image_negative_thumbnail_id_2="1133"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0166.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="534"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_positive_thumbnail_id_1="676"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0032.jpeg"
image_positive_thumbnail_id_2="613"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0095.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
